Floatz logo

CYCLOSPORIN A

Chronic Phase Chronic Myelogenous Leukemia

City of Hope Medical Centerprotein_peptidePhase 3Active
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Chronic Phase Chronic Myelogenous Leukemia cohort.

Asset / SponsorPhaseRating
Sargramostim
Virginia Commonwealth University
Phase 2BBB
FLUTICASONE
Virginia Commonwealth University
Phase 2BB
su011248
OHSU Knight Cancer Institute
Phase 2B
Tas-102
National Cancer Institute (NCI)
Phase 2B
Deferasirox
City of Hope Medical Center
Phase 2CCC

View all 12 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →